Evidence map›Paper›PMID 42781380›Full record

ArticleFrontiers in aging neuroscience2026

Integrating Baduanjin exercise into Parkinson's rehabilitation: a randomized controlled trial.

Muhammed Fatih Kavak, Nur Betül Civelek, Gülay Yalçın

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07306169 (Effect of Baduanjin Exercise on the Rehabilitation of Patients With Parkinson's Disease), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07306169 nacompletednot on this map

Effect of Baduanjin Exercise on the Rehabilitation of Patients With Parkinson's Disease: A Randomized Controlled Study

TypeinterventionalSponsorIstanbul Medipol University HospitalRan2025 to 2025Enrolled27ConditionsParkinson DiseaseArmsphysical therapy, baduanjin exercise
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Muhammed Fatih KavakDepartment of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Üsküdar University, İstanbul, Türkiye.
Nur Betül CivelekInstitute of Health Sciences, Üsküdar University, İstanbul, Türkiye.
Gülay YalçınDepartment of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Mudanya University, Bursa, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate whether adding Baduanjin exercise to conventional physiotherapy improves balance, functional mobility, walking capacity, and motor signs compared with conventional physiotherapy alone in nursing-home residents with Parkinson's disease. Methods: This assessor-blinded, two-group randomized controlled trial included 30 participants allocated equally to conventional physiotherapy (CPT) or Baduanjin plus conventional physiotherapy (BDJ + CPT). CPT consisted of supervised 45-min sessions three times weekly for 12 weeks; the intervention group received an additional 15 min of supervised Baduanjin during each session. Twenty-seven participants completed follow-up and were included in the complete-case analysis (BDJ + CPT, Results: At 12 weeks, BDJ + CPT was associated with a higher adjusted BBS score than CPT alone (adjusted mean difference, 9.93 points; 95% CI, 3.64 to 16.23; Holm-adjusted Conclusion: In this small, single-site randomized trial, adding Baduanjin to conventional physiotherapy was associated with a higher BBS score and a longer 6MWT distance at 12 weeks after baseline adjustment. Additional benefits for TUG or MDS-UPDRS III were not demonstrated. Larger, prospectively powered trials are needed to determine the specific and clinically meaningful contribution of Baduanjin to Parkinson's rehabilitation. Clinical trial registration: ClinicalTrials.gov, identifier NCT07306169.

Indexed as

Baduanjin exerciseexercise therapyParkinson’s diseasephysical therapypostural balancerehabilitation

Identifiers

PMID42781380
PMCPMC13598829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.